Kos...also IIl said this in the report
"The Company has previously advised that no adjustments will be made to the analysis to take account of the multiplicity of outcomes, but success will be judged on consistency of the outcomes rather than inferential statistical testing."
HHmmmm very vague......
Look at drug review process in report...
Iil have not done an ind application stage 4
So they are doing a 2b trial without FDA and ind consultation....
- Forums
- ASX - By Stock
- Anp Board to bring home the bacon..ROI
Kos...also IIl said this in the report "The Company has...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.9¢ | $12.63K | 158.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 273231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66500 | 0.076 |
4 | 206988 | 0.075 |
2 | 353708 | 0.074 |
1 | 100000 | 0.072 |
2 | 310000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 273231 | 2 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
0.084 | 157142 | 2 |
0.085 | 553000 | 3 |
Last trade - 15.26pm 19/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |